First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…
targeted therapy
Scientists can silence inflammatory gene responsible for a form of breast cancer
Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive…